Covid-19: Can Vaccines Keep Up With Variants? : The Economist

The race between covid-19 vaccines and variants is on. Alok Jha, The Economist’s science correspondent, and Natasha Loder, health policy editor, discuss what this means for the future

Read more of the coverage on coronavirus: econ.st/3t1L6wx

Listen to the daily podcast, Gamechangers, on mRNA technology: econ.st/38cSewe

Listen to “The Jab” podcast from Economist Radio: econ.st/3yuETKF

Watch the film about mandatory vaccines: econ.st/3DktD77

Which countries are considering a booster jab? econ.st/2WtrO6H

Why are covid variants named using the Greek alphabet?econ.st/3gwA0u3

Can vaccines help solve environmental issues? econ.st/3mB89wE

Why is the Delta variant the most dangerous mutation yet? econ.st/3sPLHBc

What’s Britain’s strategy for mass vaccination? econ.st/3yjGgvs

Where will you need proof of vaccination? econ.st/38dikiT

How the pandemic has brought re-examination of intellectual-property rights: econ.st/3kkatFG

Why are the unvaccinated at risk? econ.st/3kvjhZx

Which vaccine is the most widely accepted for international travel? econ.st/3jjqBrD

#covidvariants #johnsonandjohnsonvaccine #deltavariant #pfizervaccine #modernavaccine #coviddeltavariant #covidvaccine #coronavirusvariants #coronavirusmutations #healthcaresciencefieldofstudy #vaccineupdate #coronavirusmutation #deltavariantandvaccines #economist #economistfilms #theeconomist #covidvariantsandvaccines